March 07, 2026 | Dravya

Why Ophthalmology Drug Discovery Needs Better Preclinical Models

The field of ophthalmology has seen remarkable advances over the past two decades. Breakthroughs such as anti-VEGF thera...

READ MORE ⓘ
March 07, 2026 | Dravya

The Growing Opportunity in Ophthalmology Therapeutics

Ophthalmology is rapidly emerging as one of the most promising areas of innovation in modern medicine. With ageing popul...

READ MORE ⓘ
March 07, 2026 | Dravya

How CRO Partnerships Accelerate Ophthalmology Innovation

The development of new therapies for eye diseases is entering an exciting era. Advances in molecular biology, gene thera...

READ MORE ⓘ
Why We Founded Dravya Discovery – Building the Future of Ophthalmology Drug Discovery
March 07, 2026 | Dravya

Why We Founded Dravya Discovery – Building the Future of Ophthalmology Drug Discovery

The global burden of eye diseases continues to rise rapidly. Conditions such as age-related macular degeneration (AMD),...

READ MORE ⓘ